← Browse by Condition
Medical Condition
high risk neuroblastoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT07007117 Phase 1
Recruiting
PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma
Enrollment
38 pts
Location
United States
Sponsor
Stephan Grupp MD PhD
NCT05130255 Phase 1
Recruiting
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
Enrollment
60 pts
Location
United States
Sponsor
Y-mAbs Therapeutics